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Abstract 
Large bone defect still represent a major problem in orthopedics. A tissue engineering approach has been 
proposed where osteogenic cells, bioceramic scaffolds and growth factors can play in a role to the bone 
repair. Bone consist a mineral phase such as carbonate apatite and an organic phase such as collagen. 
Synthetic carbonate apatite ceramics are considered as promising alloplastic materials for bone substitute. 
Chitin is the organic matrix of the hard parts of exoskeleton of insect, crustacean and present in a small 
amounts in mushrooms. It is an insoluble, similar to cellulose and composed of N-acetylglucosamine unit. 
Partial deacetylation from chitin result in the formation of chitosan. Chitin’s properties as a flexible and strong 
material make it favourable as surgical thread. It has novel properties such as biocompatibility, biodegradability, 
anti bacterial, wound healing activity, tissue regeneration and hemostatic activitities. The composit from 
carbonate apatite and chitosan may have a great impact on human health care system as bioresorbable 
bone substitute. The aim of the study was to evaluate the newly bone formation on the bone healing of 
defect tibia treated with carbonate apatite-chitosan bone substitute. Eighteen Sprague Dawley rats, male, 3 
months, weighing 250-300g used in this study. Bilateral defect were created in each tibia rat. The defects were 
filled with carbonate-apatite chitosan bone substitute. The rats were sacrificed after respectively 1, 2 and 3 
weeks. The result of this study showed that carbonate apatite-chitosan significantly increased a number of 
osteoblast (p<0.05). Carbonate apatite-chitosan group showed that matrix deposition faster than the other 
groups and have a good interface with the old bone. These data indicate that carbonate apatite-chitosan are 
potential candidate for bone substitute.
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1. Introduction
Bone is composite material made up of organic 
and inorganic components. By weight, bone is 
approximately 20% water. The mineral phase of 
bone (inorganic phase) comprised approximately 
60 to 70% of the total dry bone weight while the 
remaining is comprised of organic materials (such as 
protein and collagen). The inorganic content of bone 
consists primary of calcium phosphate and calcium 
carbonate with small quantities of magnesium, 
fluoride and sodium1. 
Bone repair or regeneration is a common 
and complex clinical problem in orthopedic and 
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maxillofacial surgery. Every year, millions of people 
are suffering from bone defects arising from 
trauma, tumor or bone diseases2. Although the 
transplantation of autogenous vital bone is still the 
method of choice for the treatment of bony defects, 
alloplastic materials are often preferred because they 
are readily available and their use avoids a donor 
site defect. Several biomaterials have already been 
developed to fill and reconstruct a bone defect, such 
a natural coral, bovine porous demineralized bone, 
human demineralized bone matrix, bioactive glass 
ceramics, and calcium phosphate ceramics. Among 
these alternative materials, calcium phosphate 
ceramic (hydroxyapatite, α-tricalcium phosphate, 
or biphasic calcium phosphate) occupy a prominent 
position3,4,5,6. 
For example, hydroxyapatite (HA) has been 
widely used as bone substitute because of its 
excellent biocompatibility and osteoconductivity. 
However, it has to be noticed that bone apatite 
contains carbonate and is therefore not pure 
hydroxyapatite7. Nonstoichiometric carbonated 
apatites (C-Ap) are the main mineral components 
of human and animal hard tissues (bones and 
teeth). They are increasingly used as biocompatible 
materials for medical purposes8. Due to its superior 
bioresorption, C-Ap is the preferred candidate 
material for bone reconstructive surgery7,9,10. The 
biodegradation of C-Ap occurs by osteoclasts3. 
Chitosan has been researched for implant and 
wound healing applications. Chitosan, a natural 
biodegradable polymer, is a low acetyl substituted 
from of chitin named (1-4)-2-amino-2-deoxy-(D-
glucose). Chitin has excellent biocompatibility for 
most tissue including skin and bone. Because of 
its unique properties such as biodegradability, non 
toxicity, anti-bacterial effect and biocompatibility, 
much attention has paid to chitosan-based 
biomedical materials11,12,13. 
Since both materials have promising properties 
to be an ideal bone substitute material, a combination 
of carbonate apatite and chitosan prepared to be 
implanted in the rat tibia and will examine the bone 
regeneration after 1, 2 and 3 weeks.
2. Materials and Methods
2.1 Materials
Chitosan (90% degree of deacetylation) was 
purchased from UPT, BBPTK, LIPI, Yogyakarta, 
Indonesia. Carbonate apatite was made by mixing 
1.825 gram of calcium hydroxide with 100ml 
distilled water while 1.024ml of phosporic acid 
mixed with 100ml of distilled water. The calcium 
hydroxide solvent was placed in the stirring machine 
and stirred with the temperature set at 45°C for 2 
hours meanwhile the acid phosporic mixture was 
titrated into the calcium hydroxide solvent9. The 
titrate mixture was tested for its pH where it was 
favored to be in the range of 6.5-7.5 which was 
neutral or slighty base. Next the mixture was placed 
into an oven with the temperature set at 60°C for 
48 hours. Finally the dried substance was taken out 
and thumped and made into thin powder. The other 
material used in this study was petroleum white 
base purchased from Betraco Chemical.
2.2 Material Synthesis
The samples were prepared by mixing C-Ap and 
chitosan (1:1) and were added with petroleum 
white (1:1) to make them easy for application in the 
defect. 
2.3 Animal Model
The use of animal protocol was approved by the 
Health and Medical Research Ethics Committee of The 
Medical Faculty, Universitas Gadjah Mada. The health 
status of the animals was monitored throughout the 
entire study. The animal experiment was performed 
according to the guidelines for animal experiments 
for scientific research of the Indonesian government. 
Twenty seven healthy adult male rats were used in 
this study because their good adaptatiton ability and 
resistance (The Human Society of The United States, 
2006). Animal was housed in caged in the Integrated 





Three treatment groups and one control group for 
each implantation time (1,2,3 weeks) were prepared: 
surgery was performed under general anesthesia 
that induced by an intramuscular injection of ketalar 
ketamin and xylasin. The animal’s hind limbs was 
saved, washed and disinfected with povidone iodine. 
A longitudinal incision was made on the surface of 
both the left and right rat tibia. After exposure of the 
bone surface, a defect was created with 3X1, 25X1 
mm3 with round and fissure dental drills using low 
rotational speeds and continuous cooling with saline 
solution. Sample was implanted into the defect and 
the soft tissue was closed in separate layers, using 
resorbable vicryl 2.0 sutures. Antibiotic and analgetic 
were administrated per oral as a safety procedure in 




Fig. 1 Defect of rat tibia
sutures. Antibiotic and analgetic were 
administrated per oral as a safety procedure 

















Fig. 2. Rat tibia  
 
Specimen Preparation 
After 1, 2 and 3 weeks, the rats were 
sacrificed and the bone were retrieved for 
evaluation. The tibias were excised and 
excessive tissue was removed. The bone was 
cut with a diamond saw and the retrieved area 
of defect were divided into smaller specimens, 
suitable for histological processing. 
Subsequently, the specimens were fixed in 
10% formaldehyde for 24 hours. Plank and 
Rychlo method for decalcification and ethanol 
was used to dehydrated specimens. The 
sections were stained with Hematoxylin Eosin 
and examined by light microscopy. 
 
Statistical Analysis 
Data were statistically analyzed by two ways 
ANOVA continued by LSD test for a number of 
osteoblast and osteoclast. A p values of<0.05 




During the experimental period, all rats 
remained in good health. At the time of rat 
sacrifice, no inflammation or adverse tissue 
reaction were apparent.  
 
Histological evaluation 
Light microscopical analysis showed the bone 
ingrowth around the defect. Both treatment 
groups showed more newly bone than the 
control group in the same time implantation 
time. Two ways ANOVA analysis showed 
significant differences of osteoblast and 
osteoclast numbers between the groups 
(p<0.05). The post hoc statistical analysis by 
LSD  method showed significant difference 
only for the number of osteoblast between 
treatment and control (p<0.05) but not for  




   
(a)  C-Ap                              (b) C-Ap-chitosan                              (c) Control 
Fig.2  Light microscopy showed inflammatory cells around defect area in 1 week (100X) 
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Specimen Preparation
After 1, 2 and 3 weeks, the rats were sacriﬁced and 
the bone were retrieved for evaluation. The tibias 
were excised and excessive tissue was removed. The 
bone was cut with a diamond saw and the retrieved 
area of defect were divided into smaller specimens, 
suitable for histological processing. Subsequently, 
the specimens were ﬁxed in 10% formaldehyde for 
24 hours. Plank and Rychlo method for decalciﬁcation 
and ethanol was used to dehydrated specimens. The 
sections were stained with Hematoxylin Eosin and 
examined by light microscopy.
Statistical Analysis
Data were statistically analyzed by two ways ANOVA 
continued by LSD test for a number of osteoblast 




During the experimental period, all rats remained in 
good health. At the time of ra  sacriﬁce, no inﬂam-
mati n or adverse tissu  re ction were apparent. 
Histological evaluation
Light microscopical analysis showed the bone 
ingrowth around the defect. Both treatment groups 
showed more newly bone than the control group 
in the same time implantation time. Two ways 
ANOVA analysis showed signiﬁcant diﬀerences of 
osteoblast and osteoclast numbers between the 
groups (p<0.05). The post hoc statistical analysis 
by LSD  method showed signiﬁcant diﬀerence only 
for the number of osteoblast between treatment 
and control (p<0.05) but not for  the number of 
osteoclast (p<0.05).
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2.5 Specimen Preparation
After 1, 2 and 3 weeks, the rats were sacrificed and 
the bone were retrieved for evaluation. The tibias 
were excised and excessive tissue was removed. The 
bone was cut with a diamond sa  and the retrieve
ar a of defect were divi ed into smaller specimens,
suitable for histological processing. Subsequently,
the specimens were fixed i  10% formaldehyd  for
24 hours. Plank and Rychlo method for decalcification
and ethan l was used to dehydrated specimens. The
sections w re stained with Hemat xylin Eosin and
examined by light microscopy.
2.6 Statistical Analysis
Data were statistically analyzed by two ways ANOVA 
con nued by LSD test for a number of osteoblast 




ri g the xperiment l period, all rats remained 
in good health. At th  time of rat sacrific , no 
inflammation or adv rs  tissue action were 
apparent. 
3.2 Histological evaluation
Light microscopical analysis showed the bone 
ingrowth around the defect. Both treatment groups 
showed more newly bone than the control group 
in the same time implantation time. Two ways 
ANOVA analysis showed significant differences of 
osteoblast and osteoclast numbers between the 
groups (p<0.05). The post hoc statistical analysis 
by LSD  method showed signifi ant difference o ly 
for the number of osteoblast between reatment 
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ingrowth around the defect. Both treatment 
groups showed more newly bone than the 
control group in the same time implantation 
time. Two ways ANOVA analysis showed 
significant differences of osteoblast and 
osteoclast numbers between the groups 
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only for the number of osteoblast between 
treatment and control (p<0.05) but not for  
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Fig.2  Light microscopy showed inflammatory cells around defect area in 1 week (100X) Fig.2 Light microscopy showed inﬂammatory cells around defect area in 1 w ek (100X) 
 
   
(a) C-Ap            (b) C-Ap-chitosan             (c) Control 
Fig. 3. Light microscopy in 2 weeks (350X). The red arrow showed the bone healing area.  
There are a gap between the old and new bone (the yellow arrow) 
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Fig. 5 Histogram of osteoblast number in 
various implant time 
 
Fig. 6 Histogram of osteoclast number in 






















Fig. 3. Light microscopy in 2 weeks (350X). The red arrow showed the bone healing area. 
 There ar  a gap betwe n th  old and new bone (the yellow arrow)
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Fig. 5 Histogram of osteoblast number in 
various implant time 
 
Fig. 6 Histogram of osteoclast number in 






















Fig. 4  Light microscopy in 3 weeks (350X). Both (a) and (b) show more mature bone than (c)
 
Fig.2 Light icroscopy sho ed infla atory cells around defect area in 1 eek (100X)
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sutures. Antibiotic and analgetic ere 
ad inistrated per oral as a safety procedure 
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Speci en Preparation 
After 1, 2 and 3 eeks, the rats ere 
sacrificed and the bone ere retrieved for 
evaluation. The tibias ere excised and 
excessive tissue as re oved. The bone as 
cut ith a dia ond sa  and the retrieved area 
of defect ere divided into s aller speci ens, 
suitable for histological processing. 
Subsequently, the speci ens ere fixed in 
10  for aldehyde for 24 hours. Plank and 
Rychlo ethod for decalcification and ethanol 
as used to dehydrated speci ens. The 
sections ere stained ith He atoxylin Eosin 
and exa ined by light icroscopy. 
 
Statistical Analysis 
Data ere statistically analyzed by t o ays 
A VA continued by LSD test for a nu ber of 
osteoblast and osteoclast. A p values of<0.05 




During the experi ental period, all rats 
re ained in good health. At the ti e of rat 
sacrifice, no infla ation or adverse tissue 
reaction ere apparent.  
 
Histological evaluation 
Light icroscopical analysis sho ed the bone 
ingro th around the defect. Both treat ent 
groups sho ed ore ne ly bone than the 
control group in the sa e ti e i plantation 
ti e. T o ays A VA analysis sho ed 
significant differences of osteoblast and 
osteoclast nu bers bet een the groups 
(p<0.05). The post hoc statistical analysis by 
LSD  ethod sho ed significant difference 
only for the nu ber of osteoblast bet een 
treat ent and control (p<0.05) but not for  
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Fig. 4  Light icroscopy in 3 eeks (350X). Both (a) and (b) sho  ore ature bone than (c)
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(a) C-Ap            (b) C-Ap-chitosan             (c) Control 
Fig. 3. Light microscopy in 2 weeks (350X). The red arrow showed the bone healing area.  
There are a gap between the old and new bone (the yellow arrow) 
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Fig. 5 Histogram of osteoblast number in 
various implant time 
 
Fig. 6 Histogram of osteoclast number in 
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Fig. 3. Light microscopy in 2 weeks (350X). The red arrow showed the bone healing area.  
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Fig. 5 Histogram of osteoblast number in 
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Fig. 6 Histogram of osteoclast number in 






















Fig. 6 Histogram of osteoclast number in various implant 
time
4. Discussion
The aim of this study was to evaluate the newly bone 
formation on tibia bone defect healing treated with 
C-Ap-chitosan bone substitute. This study compared 
number of osteoblast and osteoclast in a response 
to implantation of C-Ap and C-Ap-Chitosan on 
Sprague Dawley rats. The activity of osteoblast and 
osteoclast are wich potential biochemical marker 
of bone formation and which reveal the success 
of a bone graft to initiate, support and assist bone 
regeneration14. The results of this study conﬁrmed 
that C-Ap and C-Ap-chitosan are potential to 
improve the bone regeneration. Meanwhile, C-Ap 
bone substitute showed faster bone healing process 
than C-Ap-chitosan.
Histological evaluation revealed that both the 
C-Ap and C-Ap-chitosan showed a higher number 
of osteoblast and osteoclast than the control group 
in 1 week implantation but it is opposite in 2 and 3 
weeks. The number of osteblast indicated that bone 
formation process still happend. After the maturation 
process, the osteoblast will be calciﬁed and become 
the osteocyt and continued to remodelling process 
by osteoclast. This result showed tha  the number 
of osteoblast in a control group still higher than the 
treatment groups in 2 and 3 weeks implantation 
time. It indicated that the number of osteoblast in 
a treatment groups are faster to be calciﬁed and 
remodelled by osteoclast. The decreasing number 
of osteoblast in 3 weeks implantation time indicated 
that the increasing calciﬁed process of osteoblast to 
be an osteocyt.
Carbonate ions are closely related to human 
metabolism. Bicarbonates in blood and body 
ﬂuids, whose concentration equilibrates with the 
carbonate content of bone apatites, contribute to 
the buﬀer mechanisms present14. This is an idea that 
osteoblast and osteoclast may adapt and respon 
to their surrounding environment, such as the 
carbonate concentration from bone substitute that 
is implanted in situ. Therefore, we believe that for a 
bone substitute biomaterials, C-Ap or C-Ap-chitosan 
are suitable and biocompatible and have ability to 
improve the bone healing. 
Light microscopical analysis demonstrated 
that there are a remain chitosan in 1, 2 week. It is 
indicated that chitosan is resorbsed slower than 
C-Ap. The result showed that C-Ap alone has more 
eﬀective to increase a number of osteoblast and 
osteoclast especially in 1 week implantation. 
The result show that a number of both osteoblast 
and osteoclast in a control group are highest in a 3 
weeks. It is indicate that a bone still active to repair 
the defect while in the treatment group toward 
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Fig. 3. Light microscopy in 2 weeks (350X). The red arrow showed the bone healing area.  
There are a gap between the old and new bone (the yellow arrow) 
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4. Discussion
The aim of this study was to evaluate the newly bone 
formation on tibia bone defect healing treated with 
C-Ap-chitosan bone substitute. This study compared 
number of osteoblast and osteoclast in a response 
to implantation of C-Ap and C-Ap-Chitosan on 
Sprague Dawley rats. The activity of osteoblast and 
osteoclast are wich potential biochemical marker 
of bone formation and which reveal the success 
of a bone graft to initiate, support and assist bone 
regeneration14. The results of this study conﬁrmed 
that C-Ap and C-Ap-chitosan are potential to 
improve the bone regeneration. Meanwhile, C-Ap 
bone substitute showed faster bone healing process 
than C-Ap-chitosan.
Histological evaluation revealed that both the 
C-Ap and C-Ap-chitosan showed a higher number 
of osteoblast and osteoclast than the control group 
in 1 week implantation but it is opposite in 2 and 3 
weeks. The number of osteblast indicated that bone 
formation process still happend. After the maturation 
process, the osteoblast will be calciﬁed and become 
the osteocyt and continued to remodelling process 
by osteoclast. This result showed tha  the number 
of osteoblast in a control group still higher than the 
treatment groups in 2 and 3 weeks implantation 
time. It indicated that the number of osteoblast in 
a treatment groups are faster to be calciﬁed and 
remodelled by osteoclast. The decreasing number 
of osteoblast in 3 weeks implantation time indicated 
that the increasing calciﬁed process of osteoblast to 
be an osteocyt.
Carbonate ions are closely related to human 
metabolism. Bicarbonates in blood and body 
ﬂuids, whose concentration equilibrates with the 
carbonate content of bone apatites, contribute to 
the buﬀer mechanisms present14. This is an idea that 
osteoblast and osteoclast may adapt and respon 
to their surrounding environment, such as the 
carbonate concentration from bone substitute that 
is implanted in situ. Therefore, we believe that for a 
bone substitute biomaterials, C-Ap or C-Ap-chitosan 
are suitable and biocompatible and have ability to 
improve the bone healing. 
Light microscopical analysis demonstrated 
that there are a remain chitosan in 1, 2 week. It is 
indicated that chitosan is resorbsed slower than 
C-Ap. The result showed that C-Ap alone has more 
eﬀective to increase a number of osteoblast and 
osteoclast especially in 1 week implantation. 
The result show that a number of both osteoblast 
and osteoclast in a control group are highest in a 3 
weeks. It is indicate that a bone still active to repair 
the defect while in the treatment group toward 
maturation process because almost of all the defect 
Fig. 6 Histogram of osteoclast number in v rious i plant 
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all the defect are covered by new bone (Fig.4) We 
can explain the reason of the result in a treatment 
groups that showed more osteocyt than osteoblast 
in 3 weeks. The treatment group was found to be 
more effective to stimulate bone regeneration than 
the control group.
Chitosan and its derivatives possess some 
special properties for use in regenerative medicine. 
A property of chitosan can be molded in various 
forms such as powder, paste, film, fiber and so forth 
for application with different demands. Chitosan can 
be combined with a variety of biomaterials such as 
alginate, hydroxyapatite, hyaluronic acid, calcium 
phosphate, polymethil metacrylate (PMMMA), 
poly-L- lactic acid (PLLA) and growth factors for 
potential application. Many chitosan derivatives are 
also biocompatible and non toxic with living tissues. 
Several injectable materials based on chitosan and 
its derivatives have been used as osteogenic bone 
substitutes15,16,17.
5. Conclusion
Based on the result, chitosan is a candidate to be 
used in tissue engineering as a bone substitute when 
it is combined with carbonate apatite. We suggest 
to modify the powder form to be a nanoparticle of 
chitosan to be easily resorbed in the body fluid.
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